Navigation Links
Switzerland signs the ELIXIR consortium agreement and contributes €35 million

Switzerland's State Secretary for Education, Research and Innovation, Dr Mauro Dell'Ambrogio, has signed the ELIXIR Consortium Agreement for the establishment of ELIXIR, the European Life science Infrastructure for Biological Information. This brings closer the time when five Member States will have signed, and the Consortium Agreement will enter into force. The Swiss government has committed to investing 35 million over the four-year period from 2013 to 2016. This monetary contribution is mainly provided through financial support to SIB Swiss Institute of Bioinformatics the Swiss ELIXIR Node. However, the experience and expertise of SIB are also an important part of Switzerland's participation. Access to SIB's bioinformatics core resources and many other high-quality services, as well as the benefit of its solid experience in bioinformatics training will be major assets in the launch and success of ELIXIR.

The deluge of data produced by life science researchers thanks to new-generation technologies is a very positive development, given the wealth of information hidden in this data. Our society is constantly being challenged by crucial questions related to food, energy, the environment and, of course, health. Such data is a windfall for researchers provided that both the information and the bioinformatics resources for its analysis are accessible over the long term. ELIXIR is the European consortium, whose aim is to set up and operate a sustainable European infrastructure for biological information to support life science research and its translation to medicine, the environment, the bio-industries and society. This requires international coordination and the assurance of long-term funding.

The International Consortium Agreement signed by Switzerland today is key for the set-up of ELIXIR. Niklas Blomberg, Director of ELIXIR, is "very pleased that Switzerland, a pioneer and one of the world leaders in bioinformatics, is one of the first Member States to ratify the Agreement". Switzerland, which had already signed the Memorandum of Understanding in 2011, has thus confirmed its participation in the project. Research, life sciences and bioinformatics have been strongly supported by the Swiss government for many years, which is one of the reasons why Switzerland currently has a robust bioinformatics infrastructure.

SIB, the Swiss node of ELIXIR, is pleased to lend its support to ELIXIR

Since its inception, SIB, which is celebrating its 15th anniversary this year, has positioned itself as a major contributor to the life sciences. UniProtKB/Swiss-Prot, neXtProt, STRING, SWISS-MODEL are only a few of the core resources that have been created by SIB and are available to the life science research community worldwide. In total, more than 130 resources are accessible through SIB's web portal ExPASy ( SIB, whose infrastructure and research groups are located in the major Swiss Universities and Federal Institutes of Technology, has a long experience in interinstitutional, intercantonal and international collaboration. Training the next generation of bioinformaticians is another of the Institute's roles, and demonstrates how SIB's missions are in tune with those of ELIXIR. According to Ron Appel, Executive Director of SIB, "ELIXIR will give a new dimension to European collaboration and open the door to the future of science".


Contact: Irene Perovsek
Swiss Institute of Bioinformatics

Related biology news :

1. Empa researchers join Quantis to open new branch in Switzerland
2. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
3. Leopoldina signs cooperation agreement with the Academy of Science of South Africa
4. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
5. Light and nanoprobes detect early signs of infection
6. Encouraging signs for bee biodiversity
7. Early warning signs of population collapse
8. Shedding light on a gene mutation that causes signs of premature aging
9. Genetic signs of alcoholism in women studied for the first time
10. Streams show signs of degradation at earliest stages of urban development
11. Wiley signs collaboration agreement with the Asian Federation of Biotechnology
Post Your Comments:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/9/2016)... 9, 2016 Paris Police ... video security solution to ensure the safety of people and ... during the major tournament Teleste, an international technology ... services, announced today that its video security solution will be ... back up public safety across the country. The system roll-out ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
Breaking Biology News(10 mins):
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: